Why the study?
Does percutaneous transluminal coronary angioplasty successfully dilate stenotic arteries and improve cardiac function in patients with coronary artery stenosis?
Does percutaneous transluminal coronary angioplasty successfully dilate stenotic arteries and improve cardiac function in patients with coronary artery stenosis?
Percutaneous transluminal coronary angioplasty is a feasible nonoperative technique that significantly reduces coronary artery stenosis and pressure gradients in selected patients, particularly those with single-vessel disease.
In percutaneous transluminal coronary angioplasty, a catheter system is introduced through a systemic artery under local anesthesia to dilate a stenotic artery by controlled inflation of a distensible balloon. Over the past 18 months, we have used this technic in 50 patients. The technic was successful in 32 patients, reducing the stenosis from a mean of 84 to 34 per cent (P less than 0.001) and the coronary-pressure gradient from a mean of 58 to 19 mm Hg (P less than 0.001). Twenty-nine patients showed improvement in cardiac function during follow-up examination. Because of acute deterioration in clinical status, emergency bypass was later necessary in five patients; three showed electrocardiographic evidence of infarcts. Patients with single-vessel disease appear to be most suitable for the procedure, and a short history of pain indicates the presence of a soft (distensible) atheroma likely to respond to dilatation. We estimate that only about 10 to 15 per cent of candidates for bypass surgery have lesions suitable for this procedure. A prospective randomized trial will be necessary to evaluate its usefulness in comparison with surgical and medical management.
No takes yet. Share an insight, caveat, or question.
Grüntzig et al. (1979) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: